Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc.verified

ERNA

Price:

$1.31

Market Cap:

$10.28M

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Industry

Biotechnology

IPO Date

1991-08-29

Stock Exchange

NASDAQ

Ticker

ERNA

The PE Ratio as of December 2025 (TTM) for Ernexa Therapeutics Inc. (ERNA) is 0.02

According to Ernexa Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.02. This represents a change of -100.48% compared to the average of -4.19 of the last 4 quarters.

Ernexa Therapeutics Inc. (ERNA) Historical PE Ratio (quarterly & annually)

How has ERNA PE Ratio performed in the past?

The mean historical PE Ratio of Ernexa Therapeutics Inc. over the last ten years is -44.86. The current 0.02 PE Ratio has changed -104.46% with respect to the historical average. Over the past ten years (40 quarters), ERNA's PE Ratio was at its highest in in the June 2022 quarter at 16.19. The PE Ratio was at its lowest in in the March 2020 quarter at -464.34.

Quarterly (TTM)
Annual

Average

-44.86

Median

-26.33

Minimum

-303.57

Maximum

195.61

Ernexa Therapeutics Inc. (ERNA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ernexa Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 171.96%

Maximum Annual PE Ratio = 195.61

Minimum Annual Increase = -522.04%

Minimum Annual PE Ratio = -303.57

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2.81-57.54%
2023-6.6210.44%
2022-6.00-72.93%
2021-22.14-111.32%
2020195.61-522.04%
2019-46.35-84.73%
2018-303.57112.01%
2017-143.1972.50%
2016-83.01171.96%

Ernexa Therapeutics Inc. (ERNA) Average PE Ratio

How has ERNA PE Ratio performed in the past?

The current PE Ratio of Ernexa Therapeutics Inc. (ERNA) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.14

5-year avg

31.61

10-year avg

-44.86

Ernexa Therapeutics Inc. (ERNA) PE Ratio vs. Peers

How is ERNA’s PE Ratio compared to its peers?

Ernexa Therapeutics Inc.’s PE Ratio is greater than Adaptimmune Therapeutics plc (-0.08), less than MapLight Therapeutics, Inc. (0), greater than Lunai Bioworks Inc. (-0.12), greater than ProMIS Neurosciences, Inc. (-0.36), greater than Dogwood Therapeutics, Inc. (-0.31), greater than BiomX Inc. (-0.21), greater than Moleculin Biotech, Inc. (-0.28), greater than AEON Biopharma, Inc. (-2902.68), greater than OSR Holdings, Inc. (-0.91), greater than Aethlon Medical, Inc. (-0.07),

Build a custom stock screener for Ernexa Therapeutics Inc. (ERNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ernexa Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ernexa Therapeutics Inc. (ERNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ernexa Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ernexa Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Ernexa Therapeutics Inc. (ERNA)?

What is the highest PE Ratio for Ernexa Therapeutics Inc. (ERNA)?

What is the 3-year average PE Ratio for Ernexa Therapeutics Inc. (ERNA)?

What is the 5-year average PE Ratio for Ernexa Therapeutics Inc. (ERNA)?

How does the current PE Ratio for Ernexa Therapeutics Inc. (ERNA) compare to its historical average?